Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
11(34%)
Results Posted
15%(2 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_1
1
3%
Ph early_phase_1
1
3%
Ph phase_2
1
3%
Ph not_applicable
27
84%
Ph phase_4
1
3%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution31 total trials
Early Phase 1First-in-human
1(3.2%)
Phase 1Safety & dosage
1(3.2%)
Phase 2Efficacy & side effects
1(3.2%)
Phase 4Post-market surveillance
1(3.2%)
N/ANon-phased studies
27(87.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

11

trials recruiting

Total Trials

32

all time

Status Distribution
Active(16)
Completed(13)
Terminated(1)
Other(2)

Detailed Status

Completed13
Recruiting11
Not yet recruiting3
Enrolling by invitation2
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
11
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.2%)
Phase 11 (3.2%)
Phase 21 (3.2%)
Phase 41 (3.2%)
N/A27 (87.1%)

Trials by Status

enrolling_by_invitation26%
completed1341%
terminated13%
recruiting1134%
unknown26%
not_yet_recruiting39%

Recent Activity

11 active trials
Showing 5 of 32
recruitingnot_applicable

taVNS for Persistent Symptoms From Lyme Disease

NCT05776251
enrolling_by_invitationnot_applicable

taVNS for Speech and Language Recovery in Aphasia

NCT07563387
recruitingnot_applicable

taVNS + CCT for Neurocognitive Rehab

NCT07517237
completednot_applicable

tAVNS for Stress Reduction in University Students

NCT07411846
completednot_applicable

Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Acute Pancreatitis

NCT06998784
View all 32 trials

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT05776251Not Applicable

taVNS for Persistent Symptoms From Lyme Disease

Recruiting
NCT07563387Not Applicable

taVNS for Speech and Language Recovery in Aphasia

Enrolling By Invitation
NCT07517237Not Applicable

taVNS + CCT for Neurocognitive Rehab

Recruiting
NCT07411846Not Applicable

tAVNS for Stress Reduction in University Students

Completed
NCT06998784Not Applicable

Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Acute Pancreatitis

Completed
NCT06761404Not Applicable

Non-invasive VNS in Stroke Recovery

Recruiting
NCT07325058Not Applicable

Tonic Pain and Transauricular Vagal Nerve Stimulation

Recruiting
NCT06168071Not Applicable

Transauricular Vagus Nerve Stimulation in Children

Enrolling By Invitation
NCT05871151Not Applicable

Combining VNS With PT Interventions for Individuals With PD

Completed
NCT07272954Not Applicable

Effects of Ultrasound-Guided Stellate Ganglion Block and Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Quality After Radical Mastectomy for Breast Cancer

Not Yet Recruiting
NCT07063446Not Applicable

sTMS Combined With CIMT and taVNS In Infants With Hemiplegia

Recruiting
NCT07049952Phase 2

BabySTrong II taVNS Feeding Trial

Recruiting
NCT03603730Not Applicable

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

Recruiting
NCT05554172Not Applicable

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

Recruiting
NCT06240026Not Applicable

Transauricular Vagal Nerve Stimulation, Pressure Pain and Interoception

Completed
NCT06763913Not Applicable

taVNS Reduces Postoperative Pain and Complications in Patients With Gastric and Intestinal Tumors

Completed
NCT07051694Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation as Adjuvant Treatment for Sepsis Patients

Recruiting
NCT06912386Not Applicable

Pain Relief From Dysmenorrhea Employing taVNS

Recruiting
NCT06659172Not Applicable

Effects of tVNS on Visceral Pain

Completed
NCT06700200Not Applicable

TVNS and Upper GI Motility

Not Yet Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
32